| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| Xencor Inc | |
|---|---|
| Ticker | XNCR |
| CIK # | 0001326732 |
| CUSIP | 98401F105 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 111 West Lemon Ave, Monrovia, CA 91016 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Xencor Inc | 2021-11-19 | 25.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001326732] | 10-K | |
| [0001326732] | 10-Q | |
| [0001326732] | 3 | |
| [0001326732] | 4 | |
| [0001326732] | 5 | |
| [0001326732] | 8-K | |
| [0001326732] | D | |
| [0001326732] | SC 13D | |
| [0001326732] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Desjarlais John R
Common Stock
|
2026-03-06 | Sell | 2,502 | $11.02 | 27,572 |
|
Dahiyat Bassil I
Common Stock
|
2026-03-06 | Sell | 6,606 | $11.02 | 72,798 |
|
Eckert Celia
Common Stock
|
2026-03-06 | Sell | 1,767 | $11.02 | 19,472 |
|
Cornelissen Bart Jan
Common Stock
|
2026-03-05 | Sell | 2,517 | $11.25 | 28,316 |
|
Desjarlais John R
Common Stock
|
2026-03-05 | Sell | 4,118 | $11.25 | 46,328 |
|
Eckert Celia
Common Stock
|
2026-03-05 | Sell | 3,244 | $11.25 | 36,495 |
|
Dahiyat Bassil I
Common Stock
|
2026-03-05 | Sell | 14,870 | $11.25 | 167,288 |
|
Eckert Celia
Common Stock
|
2026-03-03 | Sell | 1,492 | $11.90 | 17,755 |
|
Desjarlais John R
Common Stock
|
2026-03-03 | Sell | 2,663 | $11.90 | 31,690 |
|
Dahiyat Bassil I
Common Stock
|
2026-03-03 | Sell | 6,758 | $11.90 | 80,420 |
|
Eckert Celia
Common Stock
|
2026-03-02 | Grant | 18,680 | $0.00 | |
|
Dahiyat Bassil I
Common Stock
|
2026-03-02 | Grant | 97,291 | $0.00 | |
|
Cornelissen Bart Jan
Common Stock
|
2026-03-02 | Grant | 19,458 | $0.00 | |
|
Cornelissen Bart Jan
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 116,750 | $0.00 | |
|
Desjarlais John R
Common Stock
|
2026-03-02 | Grant | 24,907 | $0.00 | |
|
Eckert Celia
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 112,080 | $0.00 | |
|
Dahiyat Bassil I
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 583,748 | $0.00 | |
|
Desjarlais John R
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 149,440 | $0.00 | |
|
Desjarlais John R
Common Stock
|
2026-01-23 | Option exercise | 5,322 | $12.51 | 66,578 |
|
Desjarlais John R
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Option exercise | 5,322 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 203 | 82,591,825 |
| 2025-12-31 | 208 | 79,920,629 |
| 2025-09-30 | 206 | 79,764,756 |
| 2025-06-30 | 193 | 79,660,912 |
| 2025-03-31 | 203 | 74,897,884 |
| 2024-12-31 | 194 | 70,150,827 |
| 2024-09-30 | 211 | 67,490,250 |
| 2024-06-30 | 199 | 60,466,749 |
| 2024-03-31 | 202 | 62,010,997 |
| 2023-12-31 | 196 | 58,854,397 |
| 2023-09-30 | 178 | 55,178,213 |
| 2023-06-30 | 183 | 54,412,028 |